Removal Of The Femoral Arterial Catheter
In most patients, sheaths can be removed 2 hours after ANGIOMAX discontinuation
without ACT monitoring. Sheath removal has not been studied in dialysis-dependent
patients and standard hospital protocol should be followed.
Download the above poster summarizing the key steps in the removal of a femoral
arterial catheter.
Download now >>
The FREE Adobe Acrobat Reader needs to be installed on your computer in order to
view and print this document. If you do not already have this program, visit the
Adobe Web site (www.adobe.com).
(Note: you will be leaving the ANGIOMAX.com Web site.)
Safety Considerations
ANGIOMAX with provisional use of glycoprotein IIb/IIIa inhibitor is indicated for
use as an anticoagulant in patients undergoing percutaneous coronary intervention
(PCI), and in patients with or at risk for heparin-induced thrombocytopenia and
thrombosis syndrome (HIT/HITTS) undergoing PCI. ANGIOMAX is intended for use with
aspirin and has been studied only in patients receiving concomitant aspirin. ANGIOMAX
is contraindicated in patients with active major bleeding or hypersensitivity to
ANGIOMAX or its components. The most common (≥10%) adverse events for ANGIOMAX were back pain, pain, nausea, headache,
and hypotension. An unexplained fall in blood pressure or hematocrit, or any unexplained
symptom, should lead to serious consideration of a hemorrhagic event and cessation
of ANGIOMAX administration. Please see complete prescribing information.
1Mehta S et al. Cath Lab Digest. 2004;12:1-4.
2Minutello RM, Wong SC, Chou ET, et al. Angiomax facilitates early sheath
removal after coronary angioplasty: the AFRICA Study. (abstract 340). Presented
at: 15th Transcatheter Cardiovascular Therapeutics Meeting;
Washington, DC; 2003.
3 Schussler JM et al. Am J Cardiol. 2004;94:1417-1419.